pathology microbiology and immunology Archives
Oct. 13, 2021—Vanderbilt's Diagnostic Laboratory Services are undergoing a major relocation and expansion project.
Oct. 7, 2021— by Bill Snyder Like the “canary in the coal mine,” the worldwide decline of amphibian populations, including frogs, toads and salamanders, during the past 50 years may be a harbinger of emerging infections and environmental changes that endanger humankind, as well. Just as important, some amphibian species have begun to recover from the global...
Oct. 5, 2021—Biopharmaceutical company AstraZeneca has requested emergency use authorization (EUA) from the U.S. Food and Drug Administration for a long-acting antibody combination originally developed at Vanderbilt University Medical Center to protect against COVID-19.
Sep. 22, 2021—A technology developed at Vanderbilt has led to the discovery of an “ultra-potent” monoclonal antibody against multiple variants of SARS-CoV-2, the virus responsible for COVID-19, including the delta variant.
Sep. 10, 2021—Vanderbilt researchers have identified a new antibacterial mechanism that could inspire novel strategies for combating staph and other extracellular bacterial pathogens.
Aug. 12, 2021—A high-fat diet disrupts the biology of the gut’s inner lining and its microbial communities — and promotes the production of a metabolite that may contribute to heart disease, according to a study published Aug. 13 in the journal Science.
Aug. 12, 2021—A biomarker that has proven to be a predictor for response to immunotherapies in melanoma patients also has clinical relevance for breast cancer patients, according to a new study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.
Jul. 29, 2021—Vanderbilt University Medical Center’s Core Clinical Chemistry Laboratory recently celebrated the launch of its faster, higher-volume automated chemistry line.
Jul. 16, 2021—Researchers at Vanderbilt University Medical Center (VUMC) and the Baylor College of Medicine in Houston, Texas, have taken a big step toward developing targeted treatments and vaccines against a family of viruses that attacks the gastrointestinal tract.